|
Dora S.V., Khalimov Yu.Sh., Mekhtiev S.N., Lisker A.V., Zimina M.V., Semikova G.V., Volkova A.R., Cherebillo I.V., Polyakova Yu.V.
Correlation between estrogen deficiency and non-alcoholic fatty liver disease in female patients
|
№8 / 2024
|
|
Davydova N.A., Lebedev P.A., Chernyshev A.V., Kornilin D.V., Grishanov V.N., Komarova M.V.
Clinical and prognostic value of the skin autofluorescence parameter in coronary heart disease and peripheral arterial disease patients
|
№2 / 2024
|
|
Kobzeva N.D., Demidova A.A., Shlyk S.V., Martynov A.I., Shlyk I.F.
Estimation of the risk of cardiovascular events and adverse outcomes in patients with peripheral atherosclerosis
|
№1 / 2024
|
|
Loginova E.N., Nechaeva G.I., Dakuko A.N., Bogatyrev I.V., Potapov V.V., Kirichenko N.A.
Arrhythmic syndrome of undifferentiated connective tissue dysplasia
|
№9 / 2023
|
|
Lopukhov S.V., Nikiforov A.A., Filippov E.V.
Calculation of cardiovascular risk in patients with premature ovarian insufficiency depending on its etiology
|
№6 / 2023
|
|
Larina V.N., Glibko K.V., Arakelov S.E., Kasaeva D.A.
Subclinical anxiety and depression in young and middle-aged persons: Occurrence, association with cardiac risk factors and multimorbidity
|
№5 / 2023
|
|
Boeva O.I., Kokorin V.A., Latiy V.V.
Lipid-lowering therapy today and tomorrow
|
№4 / 2023
|
|
Kislyak O.A., Mikaelyan A.A., Starodubova A.V., Kosyura S.D.
Cardiovascular and metabolic risks in patients with obesity and non-alcoholic fatty liver disease
|
№3 / 2023
|
|
Gaydukova I.Z., Mazurov V.I., Inamova O.V., Zinserling A.Yu., Bashkinov R.A.
Increasing of glomeral filtration rate in the setting of serum uric acid normalization in high cardiovascular risk patients – clinical observations
|
№3 / 2023
|
|
Larina V.N., Fedorova E.V., Sayno O.V., Mironova T.N., Orlov D.A.
The incidence of abdominal obesity and its association with risk factors for cardiovascular disease in middle-aged people
|
№8 / 2022
|
|
Mazurov V.I., Gaydukova I.Z., Tsinzerling A.Yu., Bashkinov R.A., Inamova O.V., Petrova M.S.
The effect of asymptomatic hyperuricemia on the frequency and structure of comorbidity patients with rheumatoid arthritis
|
№6 / 2022
|
|
Derevyanchenko M.V., Fedotov V.V., Shaposhnikova M.Yu., Kolodin S.V.
Assessment of the risk of developing cardiovascular diseases on the SCORE-2 and SCORE 2-OP scale in patients with arterial hypertension using software tools
|
№3 / 2022
|
Русский
